Evaluation Of The Patient's Itching During Treating Hypertrophic Facial Scars By Hyaluronic Acid Injection With Automated Micro-Needling
Ziad Alkadi1, Muner Harfush2, Muaaz Alkhouli3*
1 MSc in Oral and Maxillofacial Surgery, Faculty of Dentistry, Damascus University.
2 Professor in Oral and Maxillofacial Surgery, Faculty of Dentistry, Damascus University.
3 MSc in Pediatric Dentistry, Faculty of Dentistry, Damascus University.
*Corresponding Author
Muaaz Alkhouli,
MSc in Pediatric Dentistry, Faculty of Dentistry, Damascus University, Syria.
E-mail: Muaaz.Alkhouli@outlook.com
Received: June 15, 2021; Accepted: August 30, 2021; Published: September 04, 2021
Citation:Ziad Alkadi, Muner Harfush, Muaaz Alkhouli. Evaluation Of The Patient's Itching During Treating Hypertrophic Facial Scars By Hyaluronic Acid Injection With Automated Micro-Needling. Int J Dentistry Oral Sci. 2021;8(9):4243-4248. doi: dx.doi.org/10.19070/2377-8075-21000865
Copyright:Muaaz Alkhouli©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
Background: The formation of facial scars is considered a next stage of wound healing process, which occurs when the facial
tissues are exposed to damage or surgery. These scars are sometimes pathological scars that result from an abnormal response.
While some scars may be socially acceptable, even admirable, scars of the face can be viewed as disfiguring or ugly. Facial
scars can cause significant emotional distress due to their obvious location. Hypertrophic facial scars are characterized by an
overgrowth of the collagen fibers within the scar and manifest in the form of tough nodal growths. Many treatment methods
have been used in order to manage these scars to become as close as possible to the healthy skin nearby, but their applications
was not without some unwanted side effects.
Objectives: This research studied the changes in itching during treating hypertrophic facial scars by hyaluronic acid injection
with automated micro-needling according to Patient Scar Assessment Scale (PSAS).
Material and Methods: This research was a clinical trial. 12 Patients need treatment of hypertrophic facial scars were enrolled.
12 scars were treated with hyaluronic acid injection with automated micro-needling. Four treatment sessions were done
with an interval of 30 days between each session and the next session. Four assessments of itching by patients were taken
during treatment according to Patient Scar Assessment Scale (PSAS). Results: there are no statistically significant differences
in the average assessment of the patient’s itching among the four studied sessions (P>0.05).
Conclusion: Within the limitations of this research, we demonstrated that the use of hyaluronic acid injection with automated
micro-needling in treating of hypertrophic facial scars is considered a safe technique with respect to the patient’s itching scale.
2.Introduction
3.Materials and Methods
3.Results
4.Discussion
5.Conclusion
5.References
Keywords
Dye Penetration; Glass Ionomer Cement; Microleakage.
Introduction
Scars are a common phenomenon as they develop after a skin
injury in patients of all ages [1] and the defective development of
these scars has not been understood in depth [2].
Hypertrophic scars on the face are formed following facial
wounds and various facial surgeries. The causative factors may be
excessive pulling force on the wound, bacteriosis, foreign reaction
and inherited predisposition [3].
Hypertrophic facial scars are characterized by an overgrowth of
the collagen fibers within the scar and manifest in the form of
tough nodal growths that do not expand and do not extend beyond
the edges of the original wound [4].
Although these scars do not pose a health risk, they can be very
annoying to patients, as they are painful, raised, rigid and aesthetically
unacceptable, which may negatively affect the patient,s
quality of life [1]. Therefore, these scars were considered one of
the most important challenges facing the surgeon, which requires
careful treatment later in the event that they occur [5].
Many treatment methods have been used with the aim of managing
these hypertrophic scars to become as close as possible to the
healthy skin nearby, such as treatment with corticosteroids [6],
cryotherapy [7], radiotherapy [8, 9] and laser treatment [10], but all
of these methods were not without some unwanted side effects.
Corticosteroids have been adopted with great frequency in treating hypertrophic scars by injecting triamcinolone into the scar tissue
[6], but their use was accompanied by the emergence of some
side effects such as atrophy, capillary expansion, and itching in the
injection area [11], which reduced its use and required searching
for alternative treatment methods.
Automated micro-needling has recently spread as a safe and effective
dermatological treatment, as the basis for this treatment is the
rupture of microscopic needles of old skin collagen structures by
forming thousands of microscopic holes [12]. Where studies indicate
that after pricking the skin, a group of enzymes are released;
forming what is known as the metalloproteinase matrix and is
responsible for breaking down most of the extracellular matrix
proteins during normal tissue growth and transformation [13].
The automated micro-needling technique is accompanied by
subsequent healing stages that begin with inflammation, which
manifests as visible redness for about 48 hours, and the edema is
considered uncommon [13]. Then the reproduction phase begins
immediately with the introduction of new fibers from the third
type collagen into the skin matrix, and the effect on the epidermal
stem cells and dermis is still unknown [13]. Then comes the remodeling
phase by transforming the formed collagen fibers into a
more flexible type 1 collagen [14].
The discovery of automated micro-needling technique was only a
coincidence when it recorded an unexpected improvement in the
texture and color of hypopigmented facial scars and their general
appearance after subjecting them to the camouflaging tattoo based
on needles [15], as these needles work within specific depths and
are subject to adjustment, and these depths range from 0.25 mm
to 2.5 mm [16].
The dermaroller device, or the so-called skin wheel, was first
used in automatic micro-needling, which is a grip equipped with
a cylindrical wheel bearing on its surface 192 needles of stainless
steel with a diameter 0.25 mm and a length of 1.5 mm [14]. Then
the dermapen device, or the so-called skin pen, appeared, as the
mechanisms of action of the two devices is similar in terms of
relying on microscopic skin needling to stimulate the healing process
more regularly and within microscopic areas, which is positively
reflected in improving the appearance of the skin, reshaping
it and increasing its elasticity [17], but the advantage of the dermapen
over the dermaroller is highlighted by reducing the extent
of damage to the skin [18], and thus Dermapen has received approval
from the US Food and Drug Administration and the award
for the best professional device in skin rejuvenation, as it is used
in the treatment of common acne scars, burn scars, tension lines,
wrinkles and hair loss [12, 17].
Most of the advantages regarding skin treatment with Automated
micro-needling with the dermapen are based on the absence of an
open wound in patients and there is no risk of photosensitivity in
addition to the fact that the device is an inexpensive therapeutic
alternative [19], while the disadvantage arises through the possibility
of skin bruising in the treatment area during the first two
days [12].
Hyaluronic acid is a glycosaminoglycans present in the epidermis
with a high molecular weight and its molecules are found on
the skin cell envelope and in the cellular space of skin and the
vitreous of the eye and in the joints and muscles [20], and has a
role in many important vital functions, such as regulating cellular
adhesion and cellular movement, managing differentiation, and
conferring mechanical and biological properties of tissues [21].
The first thing that hyaluronic acid was isolated from the vitreous
in the eyes of cows was later called Hyalus, and it is present in all
living species and does not require an allergy test before injection
[22].
There are two types of hyaluronic acid, either it is animal, which
is extracted from rooster combs and has a high molecular weight
and a low concentration, or it is non-animal as it is extracted by
the bacterial fermentation process of streptococcus and has a low
molecular weight and a high concentration [23].
Hyaluronic acid has been used extensively during the past two
decades in eye surgery, wound repair and arthritis treatment, due
to its water-soluble properties and its lubricant or sticky properties
[24]. With the advancement of biotechnology, this substance
has been developed into multiple forms and different molecular
sizes with the aim of using it for cosmetic purposes [23], which
prompted us to adopt it in this research in conjunction with automated
micro-needling in order to treat hypertrophic facial scars.
Materials and Methods
This research was a clinical study. And it was done from September
2018 to February 2020 at the clinic of Department of Oral
and Maxillofacial Surgery, Faculty of Dentistry, University of Damascus,
Damascus, Syria.
12 patients (5 males have 5 scars, 7 females have 7 scars) requiring
treating their scars were included in this research (Table 1). These
facial hypertrophic scars located in the maxillofacial region resulting
from oral and maxillofacial surgery operations. The mean patient
age was 29 years (Table 2). The patients were given written
information about the research, and their informed approval was
obtained.
Inclusion Criteria
• Ages of Patients from 18 to 45 years old.
• Patients have had maxillofacial surgeries more than six
months ago from the date of the operation and they complain
about the presence of supsequent facial hypertrophic
scars.
• Patients with type III or IV Fitzpatrick classification [25], the
most common type in the Middle East.
• The patient must be cooperative, mentally capable, and committed
to the boycott.
As Inclusion Criteria for the scar [26], they were
• The scar is not associated with a local or systemic infection,
gangrene, or nonvascular tissue.
• The scar should be at least 6 months old.
• In this research, the length of the scar ranged between 1-3cm,
its height was 2mm, and its width ranged between 2-3mm.
Exclusion Criteria
• Oncology patients who are subjected to radiotherapy in the face area.
• The presence of diseases that affect the healing process, such
as diabetes or immune diseases.
• The presence of bleeding disorders.
• The presence of skin diseases such as psoriasis, vitiligo and
skin infections.
• Patients who have had their scars treated with botulinum
toxin or fillers in a previous period between six and eight
months.
• Lactation or pregnancy.
Materials and tools used in the research
• Clinical examination tools: (gloves- masks- sterile gauze).
• Photography tools: digital camera.
• Sterilization tools: Hexamidine surface disinfectant, concentration
0.1 ml.
• Surface anesthetic: Cosmocaine Plus.
• Automated micro-needling device and its heads. the Dermapen
device was used, which is an advanced technology
for vertical pricking of the skin through several needles that
puncture the skin with an automatic vibratory function. The
movement of the needles up and down vertically and the
depth of entry of the needles is controlled from 0.25 mm to
2.5 mm and at seven speed levels ranging from 1 to 7 pricks
per second, and the depth of entry is adjusted according to
the target area by special keys. The device has been calibrated
in our study to be a prick depth of 2 mm and at speed levels
of 5 pricks per second, according to the instructions of the
device manufacturer [27].
• Hyaluronic acid. CytoCare was used from the French company
Revitacare, which is a mixture of 32mg/ml non-crosslinked
biotechnological hyaluronic acid and CT50 rejuvenating
complex [28]. It was filled with insulin syringes and
injected into the thread-treated scars.
Surgical Procedure
After scar was clinically examined by direct vision and ensured
that it complied with the conditions, an optical image was made
of the location of the target scar (Figure1). The treatment was
divided into 4 sessions with an interval of 30 days between each
session and the next session [29, 30], where the work was done in
each session as follows: The surface of the scar was cleaned well
with 0.01ml hexamidine solution, then the surface anesthetic was
put for 45 minutes [31], and then removed it with sterile gauze.
hyaluronic acid was applied by injecting it into the treated scar
streakly over the entire length of the scar surface (Figure 2). A
micro-needling was performed on the treated scar after preparing
the first with a new needle head and determining the appropriate
speed and depth of puncture. The dermapen was lubricated on
the skin at an angle of 90 degrees without applying any pressure,
according to the three directions of vertical, horizontal and inclined,
and the movement was steadily and in one direction (Figure
3, 4), the area was wipped with a sterile gauze. The duration
of work in each session was between 5-10 minutes [27]. Patients
were asked Post-each session not to be exposed to the sun for 24
hours after the treatment session, and were allowed to return to
their work one day after the treatment session.
Study Method
The Patient Scar Assessment Scale (PSAS) consists of 6 numerically
recorded items that give at the end a total scale number, and
the total gives the overall score for the scale [32]. The scale of
patient includes 6 questions about pain, itching, color, hardness,
thickness, and general appearance, and each of the six items has
a scale of 10 degrees, where the score of 10 corresponds to the
wrost scar that can be imagined or felt, while the score of 1 reflects
the state of normal skin (Figure 5). In this research, patients
were asked to give an overall assessment of their itching
using this scale for all treatment sessions (Figure 6).
Statistical Analysis
The sample size was calculated according to (G Power 3.1.7) program,
considering that the t– test used is: t- test for cross linked
or dependent samples and significance level: 5%, study strength:
80%, and effect size: 1.39 after 4months with maximum standard
deviations: 7.68, and then entered the information to the program
was processed, so the required sample size was 12 cases. Statistical
analysis of the variables of this research (itching scale) was
done using a program Statistical Package for the Social Sciences
(SPSS) version 20. The t-test was used to evaluate itching changes.
A dependent t-test was performed to study the significance of the
differences in the changes of itching scale. (The P- value = 0.05
was considered statistically significant).
Results
This research evaluated the changes in itching scale (Table 3). The
research showed that there are no statistically significant differences
in the average assessment of the patient’s itching among the
four studied sessions (P> 0.05) (Table 4).
B-A: In the second session - in the first session.
C-A: In the third session - in the first session.
D-A: In the fourth session - in the first session.
C-B: In the third session - in the second session.
D-B: In the fourth session - in the second session.
D-C: In the fourth session - in the third session.
Table 4. T test for dependent samples to study the changes in the itching during the four studied sessions.
Discussion
A scar is an unavoidable end result of wound healing; Scarring is a
natural process of healing after damage to the skin that extends to
the reticular dermis. While some scars may be socially acceptable,
even admirable, scars of the face can be viewed as disfiguring or
ugly [33]. Facial scars can cause significant emotional distress due
to their obvious location [34, 35]. Hypertrophic scars are characterized
by an overgrowth of the collagen fibers within the scar
and manifest in the form of tough nodal growths [4]. Many treatments
have been used in the management of hypertrophic facial
scars, but their application was not without some unwanted side
effects. Steroid injection may cause skin depression, atrophy and
itching [11, 36, 37]. Potential complications of radiation therapy
are divided into erythema or itching [38, 39]. LASERS are associated
with prolonged erythema, hence the next itch [40, 41]. Many
scar creams are available, Some creams that contain vitamin E,
its use was accompanied by the appearance of following allergic
reactions [42]. Hyaluronic acid was used In this research in
combination with automated micro-needling for treating these
scars, in contrast to studies that used micro-needling alone as a
skin treatment without applying any materials [13, 19]. The treatment
was performed in four sessions and the interval between
sessions was 30 days based on previous studies in this regard [29, 30]. From this interval between sessions given sufficient time to
effect a change in the properties of the treated scar. The patient’s
Scar Assessment Scale (PSAS) was also used, and this same scale
was adopted in similar studies [32], In contrast to the use of the
electronic Viso-scan, which gives values on skin color and scar
depth [43], but is completely unable to give values about the other
variables of scar such as itching, for example, was the variable
studied in this research.
According to this research, the changes in itching scale were
found to be not statistically significant (P> 0.05). These results
agree with Aust et al., 2011 [12]; Jeong et al., 2017 [18]; Majid et
al., 2014 [19] who Indicated the safety of using the automated
micro-needling technique in different skin treatments and treating
facial scars.
Conclusion
Within this research, we find that the use of hyaluronic acid injection
with automated micro-needling in treating of hypertrophic
facial scars is considered a safe technique with respect to the patient’s
itching scale.
References
-
[1]. Rocchietta I, Fontana F, Simion M. Clinical outcomes of vertical bone augmentation
to enable dental implant placement: a systematic review. J Clin
Periodontol. 2008 Sep;35(8 Suppl):203-15. Pubmed PMID: 18724851.
[2]. Esposito M, Grusovin MG, Felice P, Karatzopoulos G, Worthington HV, Coulthard P. The efficacy of horizontal and vertical bone augmentation procedures for dental implants - a Cochrane systematic review. Eur J Oral Implantol. 2009 Autumn;2(3):167-84. PMID: 20467628.
[3]. Marcantonio C, Nícoli LG, Pigossi SC, Araújo RFSB, Boeck EM, Junior EM. Use of alveolar distraction osteogenesis for anterior maxillary defect reconstruction. J Indian Soc Periodontol. 2019 Jul-Aug;23(4):381-386. Pubmed PMID: 31367139.
[4]. Esposito M, Grusovin MG, Felice P, Karatzopoulos G, Worthington HV, Coulthard P. The efficacy of horizontal and vertical bone augmentation procedures for dental implants - a Cochrane systematic review. Eur J Oral Implantol. 2009 Autumn;2(3):167-84. PMID: 20467628.
[5]. Navarro DM. Alveolar osteogenic distraction as method to increase the alveolar ridge. Revista Cubana de Estomatología. 2011;48(1):43-55.
[6]. Rachmiel A, Srouji S, Peled M. Alveolar ridge augmentation by distraction osteogenesis. International journal of oral and maxillofacial surgery. 2001 Dec 1;30(6):510-7.
[7]. Navarro DM. Alveolar osteogenic distraction as a method of augmentation of the alveolar ridge. Cuban Journal of Stomatology. 2011; 48 (1): 43-55.
[8]. Toledano-Serrabona J, Sánchez-Garcés MÁ, Sánchez-Torres A, Gay-Escoda C. Alveolar distraction osteogenesis for dental implant treatments of the vertical bone atrophy: A systematic review. Med Oral Patol Oral Cir Bucal. 2019 Jan 1;24(1):e70-e75. Pubmed PMID: 30573711.
[9]. Türker N, Basa S, Vural G. Evaluation of osseous regeneration in alveolar distraction osteogenesis with histological and radiological aspects. J Oral Maxillofac Surg. 2007 Apr;65(4):608-14. Pubmed PMID: 17368352.
[10]. QUEIROZ AG, SILVA YS, COSTA PJ, FERRAZ FW, NACLÉRIOHOMEM MD. Vertical bone augmentation of posterior mandibular region: a description of two surgical techniques. RGO-Revista Gaúcha de Odontologia. 2016 Jul;64:333-6.
[11]. Uckan S, Oguz Y, Bayram B. Comparison of intraosseous and extraosseous alveolar distraction osteogenesis. J Oral Maxillofac Surg. 2007 Apr;65(4):671-4. PMID: 17368362.
[12]. Li T, Zhang Y, Shao B, Gao Y, Zhang C, Cao Q, Kong L. Partially Biodegradable Distraction Implant to Replace Conventional Implants in Alveolar Bone of Insufficient Height: A Preliminary Study in Dogs. Clin Implant Dent Relat Res. 2015 Dec;17(6):1164-73. Pubmed PMID: 24888978.
[13]. Matoulas E, Nazaroglou I, Kafas P, Charitoudi D. The reconstructive potential of distraction osteogenesis on defects of the alveolar ridge before dental implants placement: a review. Research Journal of Medical Sciences. 2009;3(3):123-32.
[14]. Zaffe D, Bertoldi C, Palumbo C, Consolo U. Morphofunctional and clinical study on mandibular alveolar distraction osteogenesis. Clin Oral Implants Res. 2002 Oct;13(5):550-7. Pubmed PMID: 12453134.
[15]. Merli M, Moscatelli M, Pagliaro U, Mariotti G, Merli I, Nieri M. Implant prosthetic rehabilitation in partially edentulous patients with bone atrophy. An umbrella review based on systematic reviews of randomised controlled trials. Eur J Oral Implantol. 2018;11(3):261-280. PMID: 30246181.
[16]. Barbu HM, Andreescu CF, Lorean A, Kolerman R, Moraru L, Mortellaro C, Mijiritsky E. Comparison of Two Techniques for Lateral Ridge Augmentation in Mandible With Ramus Block Graft. J Craniofac Surg. 2016 May;27(3):662-7. Pubmed PMID: 27092913.
[17]. von Arx T, Buser D. Horizontal ridge augmentation using autogenous block grafts and the guided bone regeneration technique with collagen membranes: a clinical study with 42 patients. Clin Oral Implants Res. 2006 Aug;17(4):359-66. Pubmed PMID: 16907765.
[18]. Chiapasco M, Lang NP, Bosshardt DD. Quality and quantity of bone following alveolar distraction osteogenesis in the human mandible. Clin Oral Implants Res. 2006 Aug;17(4):394-402. Pubmed PMID: 16907770.
[19]. Elo JA, Herford AS, Boyne PJ. Implant success in distracted bone versus autogenous bone-grafted sites. J Oral Implantol. 2009;35(4):181-4. Pubmed PMID: 19813422.
[20]. Laster Z, Rachmiel A, Jensen OT. Alveolar width distraction osteogenesis for early implant placement. J Oral Maxillofac Surg. 2005 Dec;63(12):1724-30. doi: 10.1016/j.joms.2005.09.001. Erratum in: J Oral Maxillofac Surg. 2006 Mar;64(3):566. Pubmed PMID: 16297692.
[21]. Runyan CM, Gabrick KS. Biology of Bone Formation, Fracture Healing, and Distraction Osteogenesis. J Craniofac Surg. 2017 Jul;28(5):1380-1389. Pubmed PMID: 28562424.
[22]. Block MS, Chang A, Crawford C. Mandibular alveolar ridge augmentation in the dog using distraction osteogenesis. J Oral Maxillofac Surg. 1996 Mar;54(3):309-14. doi: 10.1016/s0278-2391(96)90750-8. PMID: 8600238.
[23]. Marchetti C, Corinaldesi G, Pieri F, Degidi M, Piattelli A. Alveolar distraction osteogenesis for bone augmentation of severely atrophic ridges in 10 consecutive cases: a histologic and histomorphometric study. J Periodontol. 2007 Feb;78(2):360-6. Pubmed PMID: 17274727.
[24]. De Vos W, Casselman J, Swennen GR. Cone-beam computerized tomography (CBCT) imaging of the oral and maxillofacial region: a systematic review of the literature. Int J Oral Maxillofac Surg. 2009 Jun;38(6):609-25. Pubmed PMID: 19464146.
[25]. Al-Kassaby A, Shindy M. Comparing the duration of different phases of vertical alveolar distraction between ultrasound treated and control group in anterior mandible. International Journal of Oral and Maxillofacial Surgery. 2019 May 1;48:54.